Accuray Inc (ARAY) Stock Price, Quote & News

Company Profile

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tu...

Industry: Medical Devices

Sector: Healthcare

Phone: 608 824 2800

Fax: 608 824 2996

Website: www.accuray.com

Address:

1240 Deming Way, Madison, United States

Sammy2425 May. 29 at 5:10 PM

$ARAY the shakeout before the breakout! Wait till close and scoop GEMS!

0 · Reply

anicechineseguy May. 29 at 4:45 PM

$ARAY https://www.openpr.com/news/4519443/radiotherapy-market-key-players-siemens-healthineers-ag any thought?

1 · Reply

arealchineseguy May. 29 at 3:47 PM

$ARAY i wish they can sell the company, for one dollar a share

1 · Reply

Sammy2425 May. 29 at 3:14 PM

$ARAY the usual dips Before the runs. Follow the volume Pure Gem

0 · Reply

Sammy2425 May. 29 at 1:58 PM

$ARAY $ARAY nice volume. Day after day. In the absence of news VOLUME wil always be your guide. ARAY is relevant.

0 · Reply

Zskylar May. 29 at 1:25 PM

$ARAY can we get some green

0 · Reply

Invest2live May. 28 at 7:36 PM

$AIM 78% in two days; congrats 🌟🌿🔆 Checkout $$ARAY and $TOVX; do your DD and get in. All the best.

0 · Reply

ZdP2 May. 28 at 6:47 PM

$ARAY watching to see if this holds. Looks undervalued to me, but they still have a high debt ratio so I'm cautious...

1 · Reply

Sammy2425 May. 28 at 2:31 PM

$ARAY in the absence of news the VOLUME will always be your guide

0 · Reply

Zskylar May. 28 at 2:24 PM

$ARAY upwards

0 · Reply

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

2026-05-12T09:10:10.000Z - 17 days ago

Accuray downgraded to Hold from Buy at Jefferies

2026-05-07T11:42:52.000Z - 22 days ago

Accuray downgraded to Neutral from Buy at BTIG

2026-05-07T01:32:39.000Z - 22 days ago

Accuray reports Q3 EPS (9c) vs. (1c) last year

May 6, 2026, 4:30 PM EDT - 22 days ago

Accuray Earnings Call Transcript: Q3 2026

May 6, 2026, 4:30 PM EDT - 22 days ago

Accuray Earnings release: Q3 2026

May 6, 2026, 4:30 PM EDT - 22 days ago

Accuray Quarterly report: Q3 2026

May 6, 2026, 4:30 PM EDT - 22 days ago

Accuray Slides: Q3 2026

May 6, 2026, 4:05 PM EDT - 22 days ago

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Apr 22, 2026, 4:05 PM EDT - 5 weeks ago

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

2026-04-06T13:22:58.000Z - 7 weeks ago

Accuray names Paul Miele as Chief Commercial Officer

Apr 6, 2026, 9:00 AM EDT - 7 weeks ago

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

2026-02-17T21:31:56.000Z - 3 months ago

Accuray files to sell 7M shares of common stock for holders

Feb 17, 2026, 7:00 AM EST - 3 months ago

Accuray Registration statement: Registration Filing

2026-02-05T12:20:14.000Z - 4 months ago

Accuray price target lowered to $2 from $4 at BTIG

Feb 4, 2026, 4:30 PM EST - 4 months ago

Accuray Earnings Call Transcript: Q2 2026

Feb 4, 2026, 4:30 PM EST - 4 months ago

Accuray Quarterly report: Q2 2026

Feb 4, 2026, 4:30 PM EST - 4 months ago

Accuray Earnings release: Q2 2026

Feb 4, 2026, 4:30 PM EST - 4 months ago

Accuray Slides: Q2 2026

2026-02-04T21:17:14.000Z - 4 months ago

Accuray sees FY26 revenue $440M-$450M

2026-02-04T21:10:20.000Z - 4 months ago

Accuray reports Q2 EPS (11c) vs. 2c last year

Feb 4, 2026, 4:05 PM EST - 4 months ago

Accuray Reports Fiscal 2026 Second Quarter Financial Results

Jan 21, 2026, 4:05 PM EST - 4 months ago

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

2025-12-15T22:05:09.000Z - 5 months ago

Accuray to reduce headcount by 15%, outsource non-core activities

Dec 15, 2025, 5:00 PM EST - 5 months ago

Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

Nov 5, 2025, 4:30 PM EST - 7 months ago

Accuray Earnings Call Transcript: Q1 2026

Nov 5, 2025, 4:30 PM EST - 7 months ago

Accuray Earnings release: Q1 2026

Nov 5, 2025, 4:30 PM EST - 7 months ago

Accuray Quarterly report: Q1 2026

Nov 5, 2025, 4:30 PM EST - 7 months ago

Accuray Slides: Q1 2026

2025-11-05T21:22:44.000Z - 7 months ago

Accuray reports Q1 EPS (18c) vs (4c) last year

Nov 5, 2025, 4:05 PM EST - 7 months ago

Accuray Reports Fiscal 2026 First Quarter Financial Results

Oct 31, 2025, 4:03 PM EDT - 7 months ago

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Oct 28, 2025, 7:35 AM EDT - 7 months ago

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

2025-10-20T13:30:30.000Z - 7 months ago

Accuray sees Q1 revenue $92.5M-$94M, consensus $91.35M

2025-10-20T13:25:17.000Z - 7 months ago

Accuray appoints Steve La Neve as CEO

Oct 20, 2025, 9:20 AM EDT - 7 months ago

Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

Oct 20, 2025, 8:00 AM EDT - 7 months ago

Accuray Proxy statement: Proxy Filing

2025-10-08T11:45:18.000Z - 8 months ago

Accuray announces first patient treated in Melbourne with CyberKnife S7 System

Oct 8, 2025, 7:35 AM EDT - 8 months ago

Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System

Oct 1, 2025, 8:00 AM EDT - 8 months ago

Accuray Proxy statement: Proxy Filing

Oct 1, 2025, 8:00 AM EDT - 8 months ago

Accuray Proxy statement: Proxy Filing

2025-09-30T11:40:23.000Z - 8 months ago

Accuray, University of Wisconsin-Madison sign memorandum of understanding

Sep 30, 2025, 7:35 AM EDT - 8 months ago

Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

Sep 26, 2025, 7:35 AM EDT - 8 months ago

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

Sep 11, 2025, 4:10 PM EDT - 9 months ago

Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

2025-08-14T11:26:17.000Z - 10 months ago

Accuray price target raised to $5 from $4 at BTIG

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Accuray Earnings Call Transcript: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Accuray Annual report: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Accuray Earnings release: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Accuray Slides: Q4 2025

2025-08-13T20:21:28.000Z - 10 months ago

Accuray Sees FY26 revenue $471M-$485M, consensus $445.07M

2025-08-13T20:15:23.000Z - 10 months ago

Accuray reports Q4 EPS 1c vs. 3c last year

Aug 13, 2025, 4:05 PM EDT - 10 months ago

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

2025-07-28T20:17:14.000Z - 10 months ago

Accuray files to sell 23.43M shares of common stock for holders

Jul 28, 2025, 8:00 AM EDT - 10 months ago

Accuray Registration statement: Registration Filing

Jun 6, 2025, 7:30 AM EDT - 1 year ago

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Jun 4, 2025, 5:30 PM EDT - 1 year ago

Accuray Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 7:30 PM EDT - 1 year ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

May 7, 2025, 7:35 AM EDT - 1 year ago

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

May 5, 2025, 4:10 PM EDT - 1 year ago

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Earnings Call Transcript: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Quarterly report: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Earnings release: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Slides: Q3 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Apr 3, 2025, 7:35 AM EDT - 1 year ago

Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting

Mar 12, 2025, 7:30 AM EDT - 1 year ago

Accuray to Participate at 37th Annual Roth Conference

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Earnings Call Transcript: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Earnings release: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Quarterly report: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Slides: Q2 2025

Feb 5, 2025, 4:05 PM EST - 1 year ago

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Jan 23, 2025, 7:35 AM EST - 1 year ago

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Jan 22, 2025, 4:05 PM EST - 1 year ago

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Jan 21, 2025, 9:15 AM EST - 1 year ago

Leonel Peralta to Join Accuray as Chief Operations Officer

Jan 13, 2025, 3:00 PM EST - 1 year ago

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

Dec 18, 2024, 7:35 AM EST - 1 year ago

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Earnings Call Transcript: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Quarterly report: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Earnings release: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Slides: Q1 2025

Nov 6, 2024, 4:05 PM EST - 1 year ago

Accuray Reports Fiscal 2025 First Quarter Financial Results

Oct 23, 2024, 4:05 PM EDT - 1 year ago

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Accuray Appoints Michael Murphy as VP, Corporate Controller

Oct 15, 2024, 8:45 AM EDT - 1 year ago

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Accuray Proxy statement: Proxy Filing

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Accuray Proxy statement: Proxy Filing

Sep 30, 2024, 7:35 AM EDT - 1 year ago

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Sep 10, 2024, 5:30 PM EDT - 1 year ago

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

Sep 3, 2024, 4:10 PM EDT - 1 year ago

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Aug 27, 2024, 7:35 AM EDT - 1 year ago

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Accuray Earnings Call Transcript: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Accuray Annual report: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Accuray Earnings release: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Accuray Slides: Q4 2024

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

Aug 13, 2024, 7:35 AM EDT - 1 year ago

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

Jun 27, 2024, 7:35 AM EDT - 2 years ago

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

Jun 20, 2024, 7:35 AM EDT - 2 years ago

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

Jun 12, 2024, 7:35 AM EDT - 2 years ago

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

Jun 5, 2024, 7:30 AM EDT - 2 years ago

Accuray Transcript: Jefferies Global Healthcare Conference

May 22, 2024, 4:30 PM EDT - 2 years ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings Call Transcript: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Quarterly report: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings release: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Slides: Q3 2024

May 1, 2024, 4:06 PM EDT - 2 years ago

Accuray Reports Fiscal 2024 Third Quarter Financial Results

Apr 25, 2024, 7:35 AM EDT - 2 years ago

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Apr 18, 2024, 7:35 AM EDT - 2 years ago

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Apr 17, 2024, 4:05 PM EDT - 2 years ago

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

Mar 26, 2024, 7:35 AM EDT - 2 years ago

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Sammy2425 May. 29 at 5:10 PM

$ARAY the shakeout before the breakout! Wait till close and scoop GEMS!

0 · Reply

anicechineseguy May. 29 at 4:45 PM

$ARAY https://www.openpr.com/news/4519443/radiotherapy-market-key-players-siemens-healthineers-ag any thought?

1 · Reply

arealchineseguy May. 29 at 3:47 PM

$ARAY i wish they can sell the company, for one dollar a share

1 · Reply

Sammy2425 May. 29 at 3:14 PM

$ARAY the usual dips Before the runs. Follow the volume Pure Gem

0 · Reply

Sammy2425 May. 29 at 1:58 PM

$ARAY $ARAY nice volume. Day after day. In the absence of news VOLUME wil always be your guide. ARAY is relevant.

0 · Reply

Zskylar May. 29 at 1:25 PM

$ARAY can we get some green

0 · Reply

Invest2live May. 28 at 7:36 PM

$AIM 78% in two days; congrats 🌟🌿🔆 Checkout $$ARAY and $TOVX; do your DD and get in. All the best.

0 · Reply

ZdP2 May. 28 at 6:47 PM

$ARAY watching to see if this holds. Looks undervalued to me, but they still have a high debt ratio so I'm cautious...

1 · Reply

Sammy2425 May. 28 at 2:31 PM

$ARAY in the absence of news the VOLUME will always be your guide

0 · Reply

Zskylar May. 28 at 2:24 PM

$ARAY upwards

0 · Reply

stayenvious May. 28 at 2:17 PM

$ARAY LFGGGGGGG SAVE MEEEE

0 · Reply

trufflehog May. 28 at 2:10 PM

$ARAY

0 · Reply

andrewh2024 May. 28 at 1:46 PM

$ARAY they keep trying to break the structure but without success. 40s soon. NFA

0 · Reply

Sammy2425 May. 28 at 12:22 PM

$ARAY going private. Longs in under 1.00 will benefit quite well. Watch and learn. Pure GEM!

0 · Reply

andrewh2024 May. 28 at 11:48 AM

$ARAY interesting spike PM. Might mean nothing. Or they could be testing it for a run. Anyway, as long as the structure holds at .36-.37 this has a chance. Looking at yesterday's AH and today's PM volume is still there. With these pennies the move is often out of nowhere. At least this company has a real tangible product. NFA GLTA

0 · Reply